Cardiomyopathies are a heterogeneous group of myocardial disorders of mostly unknown
etiology, and they occur commonly in cats. In some cats, they are well‐tolerated and are …

Practical relevance: Hypertrophic cardiomyopathy (HCM) is the most common form of feline
cardiomyopathy observed clinically and may affect up to approximately 15% of the domestic …

We sought to establish a large animal model of inherited hypertrophic cardiomyopathy
(HCM) with sufficient disease severity and early penetrance for identification of novel …

Client-owned cats who underwent a post-mortem examination (n= 3,108) at a veterinary
medical teaching hospital between 1989 and 2019 were studied to determine longevity and …

Objectives To systematically review available evidence and establish guidelines related to
the risk of developing thrombosis and the management of small animals with …

Objectives Thrombosis is a well‐recognized phenomenon in dogs and cats with a significant
impact on morbidity and mortality. Despite growing awareness of thrombosis and increased …

Background The natural history of hypertrophic cardiomyopathy (HCM) in cats has been
mainly studied in cats referred for suspected heart disease, which can skew the results …

Objectives Feline arterial thromboembolism (ATE), an often devastating outcome, was
recently shown to affect 11.3% of cats with hypertrophic cardiomyopathy over 10 years …

Practical relevance: The feline cardiomyopathies are the most prevalent type of heart
disease in adult domestic cats. Several forms have been identified (see Parts 2 and 3), with …

Background Dual antithrombotic treatment (DAT) with clopidogrel and rivaroxaban
sometimes is prescribed to cats with hypertrophic cardiomyopathy at risk of …